FIL Ltd has opened a new $372.3M position in $VRNA, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $VRNA.
$VRNA Hedge Fund Activity
We have seen 135 institutional investors add shares of $VRNA stock to their portfolio, and 188 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIL LTD added 3,488,500 shares (+inf%) to their portfolio in Q3 2025, for an estimated $372,257,835
- BLACKROCK, INC. added 3,483,014 shares (+1013.4%) to their portfolio in Q3 2025, for an estimated $371,672,423
- GOLDMAN SACHS GROUP INC added 1,575,889 shares (+151.3%) to their portfolio in Q2 2025, for an estimated $149,047,581
- MORGAN STANLEY removed 1,441,797 shares (-88.8%) from their portfolio in Q2 2025, for an estimated $136,365,160
- BARCLAYS PLC added 1,283,105 shares (+1160.0%) to their portfolio in Q3 2025, for an estimated $136,920,134
- MAVERICK CAPITAL LTD removed 1,261,639 shares (-70.7%) from their portfolio in Q2 2025, for an estimated $119,325,816
- SYQUANT CAPITAL SAS added 1,208,312 shares (+inf%) to their portfolio in Q3 2025, for an estimated $128,938,973
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VRNA Insider Trading Activity
$VRNA insiders have traded $VRNA stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $VRNA stock by insiders over the last 6 months:
- DAVID ZACCARDELLI (President and CEO) has made 0 purchases and 5 sales selling 1,008,912 shares for an estimated $11,040,975.
- MARK W HAHN (Chief Financial Officer) has made 0 purchases and 5 sales selling 1,008,912 shares for an estimated $11,040,181.
- ANDREW FISHER (General Counsel) has made 0 purchases and 3 sales selling 169,584 shares for an estimated $1,733,569.
- VIKAS SINHA has made 0 purchases and 2 sales selling 164,328 shares for an estimated $1,559,813.
- KATHLEEN A. RICKARD (Chief Medical Officer) sold 58,336 shares for an estimated $766,750
- MICHAEL AUSTWICK sold 11,288 shares for an estimated $148,366
- MARTIN EDWARDS sold 10,808 shares for an estimated $142,057
- KENNETH CUNNINGHAM sold 10,808 shares for an estimated $142,057
- LISA DESCHAMPS sold 9,464 shares for an estimated $124,391
- MAHENDRA SHAH sold 3,608 shares for an estimated $47,422
- DAVID R EBSWORTH sold 1,904 shares for an estimated $25,025
- CHRISTINA ACKERMANN sold 1,808 shares for an estimated $23,763
- JAMES ALOYSIUS BRADY sold 824 shares for an estimated $10,830
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNA Analyst Ratings
Wall Street analysts have issued reports on $VRNA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 10/08/2025
- Wolfe Research issued a "Outperform" rating on 07/01/2025
- Piper Sandler issued a "Overweight" rating on 06/23/2025
- Wells Fargo issued a "Overweight" rating on 06/20/2025
- Roth Capital issued a "Buy" rating on 06/18/2025
To track analyst ratings and price targets for $VRNA, check out Quiver Quantitative's $VRNA forecast page.
$VRNA Price Targets
Multiple analysts have issued price targets for $VRNA recently. We have seen 10 analysts offer price targets for $VRNA in the last 6 months, with a median target of $107.0.
Here are some recent targets:
- Olivia Brayer from Cantor Fitzgerald set a target price of $100.0 on 10/08/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $107.0 on 07/14/2025
- Tiago Fauth from Wells Fargo set a target price of $107.0 on 07/10/2025
- Suji Jeong from Jefferies set a target price of $107.0 on 07/09/2025
- Edward Nash from Canaccord Genuity set a target price of $107.0 on 07/09/2025
- Andy Chen from Wolfe Research set a target price of $170.0 on 07/01/2025
- Yasmeen Rahimi from Piper Sandler set a target price of $160.0 on 06/23/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $VRNA ticker page for more data.
